Skip to main content

View full-text article in PMC

. 2019 Nov 29;10:2755. doi: 10.3389/fimmu.2019.02755

Table 4.

Frequency of the KIR3DL1 functional polymorphism in BD patients and controls stratified according to the HLA-B51.

	B51+				B51–
	BD		Controls		BD		Controls
	185		69		250		370
	n	%	n	%	n	%	n	%
3DL1^Exp/3DL1^Exp	76	41.1	25	36.2	90	36.0	115	31.1
3DL1^Exp/3DL1^Null	28	15.1	11	15.9	46	18.4	78	21.1
3DL1^Exp/3DS1	53	28.7	19	27.5	75	30.0	106	28.6
3DL1^Null/3DL1^Null	7	3.8	3	4.3	7	2.8	15	4.1
3DL1^Null/3DS1	11	5.9	11	15.9	16	6.4	39	10.5
3DS1/3DS1	10	5.4	0	0.0	16	6.4	17	4.6
3DL1^Exp	233	0.63	80	0.58	301	0.60	414	0.56
3DL1^Null	53	0.14	28	0.20	76	0.15	147	0.20
3DS1	84	0.23	30	0.22	123	0.25	179	0.24